World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
88
Citations
26760
World Ranking
13219
National Ranking
6736

Robert G. Gish publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Robert G. Gish sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 449 publications — 49th percentile

49% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Robert G. Gish D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Robert G. Gish sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 88 D-Index — 36th percentile

36% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Robert G. Gish is affiliated with the University of Nevada Reno in the United States. Their research primarily focuses on fields related to medicine, with specific expertise in epidemiology and hepatology. The scientist has contributed extensively to the study of liver diseases, particularly hepatitis B and C viruses, as well as liver disease diagnosis and treatment.

The main fields of study in their work include:

  • Medicine

Within this broad category, their subfields of study are:

  • Epidemiology
  • Hepatology
  • Surgery
  • Pulmonary and Respiratory Medicine
  • Infectious Diseases

Their research covers several key topics, including:

  • Liver Disease Diagnosis and Treatment
  • Hepatitis C virus research
  • Hepatitis B Virus Studies
  • Liver Diseases and Immunity
  • Hepatitis Viruses Studies and Epidemiology
  • Pediatric Hepatobiliary Diseases and Treatments
  • Liver Disease and Transplantation

Robert G. Gish has published in a variety of academic journals, often focusing on hepatology and gastroenterology. The venues with the highest number of their publications include:

  • Journal of Hepatology
  • Gastroenterology
  • The American Journal of Gastroenterology
  • Hepatology
  • Journal of Viral Hepatitis

Selected recent papers authored or coauthored by Robert G. Gish include:

  • "Prevalence of Chronic Hepatitis B Virus Infection in the United States," 2020, The American Journal of Gastroenterology
  • "An Updated Assessment of Chronic Hepatitis B Prevalence Among Foreign-Born Persons Living in the United States," 2021, Hepatology
  • "Combination treatments including the small-interfering RNA JNJ-3989 induce rapid and sometimes prolonged viral responses in patients with CHB," 2022, Journal of Hepatology
  • "Incorporating fatty liver disease in multidisciplinary care and novel clinical trial designs for patients with metabolic diseases," 2021, The Lancet. Gastroenterology & hepatology
  • "A multi-analyte cell-free DNA-based blood test for early detection of hepatocellular carcinoma," 2022, Hepatology Communications

The scientist frequently collaborates with several coauthors, including:

  • Robert J. Wong
  • Ira M. Jacobson
  • Chari Cohen
  • Ankita Kaushik
  • Joseph K. Lim

Best Publications

  • A comparison of entecavir and lamivudine for HBeAg-positive chronic hepatitis B

    Ting Tsung Chang;Robert G. Gish;Robert De Man;Adrian Gadano

  • American Gastroenterological Association Institute Guideline on the Prevention and Treatment of Hepatitis B Virus Reactivation During Immunosuppressive Drug Therapy

    Robert P. Perrillo;Robert Gish;Yngve T. Falck-Ytter

  • Primary biliary cirrhosis in monozygotic and dizygotic twins: Genetics, epigenetics, and environment ☆

    Carlo F Selmi;Carlo F Selmi;Marlyn J. Mayo;Nancy Bach;Hiromi Ishibashi

  • Changing nomenclature for PBC: from ‘cirrhosis’ to ‘cholangitis’

    Ulrich H W Beuers;M Eric Gershwin;Robert G Gish;Pietro Luigi Invernizzi

  • Minimal criteria for placement of adults on the liver transplant waiting list: A report of a national conference organized by the American Society of Transplant Physicians and the American Association for the Study of Liver Diseases

    Michael R. Lucey;Kimberly A. Brown;Gregory T. Everson;John J. Fung

  • A multicenter United States-Canadian trial to assess lamivudine monotherapy before and after liver transplantation for chronic hepatitis B.

    Robert P. Perrillo;Teresa Wright;Jorge Rakela;Gary Levy

  • RNAi-based treatment of chronically infected patients and chimpanzees reveals that integrated hepatitis B virus DNA is a source of HBsAg

    Christine I. Wooddell;Man Fung Yuen;Henry Lik Yuen Chan;Robert G. Gish

  • Entecavir therapy for up to 96 weeks in patients with HBeAg-positive chronic hepatitis B.

    Robert G. Gish;Anna S. Lok;Ting Tsung Chang;Robert A. de Man

  • Immunoregulatory cytokines in chronic hepatitis C virus infection: Pre‐ and posttreatment with interferon alfa

    Thomas V. Cacciarelli;Olivia M. Martinez;Robert G. Gish;Janeth C. Villanueva

  • Phenotypes of apolipoprotein B and apolipoprotein E after liver transplantation.

    M F Linton;R Gish;S T Hubl;E Bütler

  • Hepatitis B virus S mutants in liver transplant recipients who were reinfected despite hepatitis B immune globulin prophylaxis.

    Marc G. Ghany;Brick Ayola;Federico G. Villamil;Robert G. Gish

  • Peginterferon alfa-2b and weight-based or flat-dose ribavirin in chronic hepatitis C patients: A randomized trial

    Ira M. Jacobson;Robert S. Brown;Bradley Freilich;Nezam Afdhal

  • Multicenter study of lamivudine therapy for hepatitis B after liver transplantation

    Robert Perrillo;Jorge Rakela;Jules Dienstag;Gary Levy

  • Sexual transmission of hepatitis C virus among monogamous heterosexual couples: The HCV partners study

    Norah A. Terrault;Jennifer L. Dodge;Edward L. Murphy;Edward L. Murphy;John E. Tavis

  • Hepatitis B virus genotypes and virologic response in 694 patients in phase III studies of adefovir dipivoxil

    Chris Westland;William Delaney;Huiling Yang;Shan-shan Chen

  • Severe hepatotoxicity associated with nevirapine use in HIV-infected subjects.

    Ian Sanne;Herve Mommeja-Marin;John Hinkle;John A. Bartlett

  • A Dose-Ranging Study of the Efficacy and Tolerability of Entecavir in Lamivudine-refractory Chronic Hepatitis B Patients

    Ting–Tsung Chang;Robert G. Gish;Stephanos J. Hadziyannis;Janusz Cianciara

  • Influence of Hepatitis B Virus Genotypes on the Intra- and Extracellular Expression of Viral DNA and Antigens

    Masaya Sugiyama;Yasuhito Tanaka;Takanobu Kato;Etsuro Orito

  • Phase III Randomized Controlled Trial Comparing the Survival of Patients With Unresectable Hepatocellular Carcinoma Treated With Nolatrexed or Doxorubicin

    Robert G. Gish;Camillo Porta;Lucian Lazar;Paul Ruff

  • Minimal criteria for placement of adults on the liver transplant waiting list: a report of a national conference organized by the American Society of Transplant Physicians and the American Association for the Study of Liver Diseases.

    Michael R. Lucey;Kimberly A. Brown;Gregory T. Everson;John J. Fung

Frequent Co-Authors

Stephen Locarnini
Stephen Locarnini Melbourne Health
Ching-Lung Lai
Ching-Lung Lai University of Hong Kong
Teresa L. Wright
Teresa L. Wright GlaxoSmithKline (United States)
Masashi Mizokami
Masashi Mizokami National Center For Global Health and Medicine
Emmet B. Keeffe
Emmet B. Keeffe Stanford University
Etsuro Orito
Etsuro Orito Japanese Red Cross Nagoya Daini Hospital
Johnson Y.N. Lau
Johnson Y.N. Lau Hong Kong Baptist University
Kris V. Kowdley
Kris V. Kowdley Washington State University
M. Eric Gershwin
M. Eric Gershwin University of California, Davis
Carlo Ferrari
Carlo Ferrari University of Parma

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re interested in expanding your healthcare career beyond traditional medical degrees, numerous flexible online options are available. For nurses aiming to advance their expertise without a lengthy break from employment, exploring affordable dnp programs can open opportunities for leadership and advanced practice.

Those at the start of their clinical career may benefit from a lpn program, which offers a fast entry point into the nursing field. Licensed Practical Nurse programs are ideal for gaining practical experience and can often be completed quickly online.

If you have a particular interest in mental health, consider the shortest pmhnp program online. Psychiatric Mental Health Nurse Practitioner degrees are in high demand and can add specialization to your resume in less time than traditional pathways.

For those seeking non-clinical roles, online healthcare administration programs provide leadership skills needed to manage hospitals, clinics, and other health organizations. Each of these flexible programs can help you shape a rewarding career in the evolving world of healthcare.

Best Scientists Citing Robert G. Gish

Trending Scientists

Recently Published Articles